CSBR (Champions Oncology) Short Ratio


CSBR Champions Oncology Inc CSBR
61 GF Score
Price $5.82
GF Value $6.65
Valuation Modestly Undervalued
! 2 Warning Signs
View Full Analysis

What is Champions Oncology Short Ratio?

Short Ratio is a metric signaling prevailing investors' sentiment with a company. It represents the number of days it takes short sellers on average to repurchase all the shares short.

Due to the license agreement change with our data vendor, Short Interest related data on GuruFocus will no longer be updated. Existing data will remain as-is, while new data will not be available, except for certain Australian and Canadian stocks.

CSBR
61GF Score
Champions Oncology Inc CSBR
Short Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Champions Oncology (CSBR) Overvalued in 2026?

Based on GuruFocus' analysis, Champions Oncology stock appears to be undervalued. The current stock price of $5.82 is trading 12.5% below its estimated GF Value™ of $6.65. GuruFocus considers Champions Oncology to be Modestly Undervalued.

Key valuation signals for CSBR:

  • Short Ratio:
  • GF Value™: $6.65 vs. price of $5.82 (12.5% below fair value)
  • GF Score™: 61/100 with 2 warning signs

No single metric tells the full story. See the CSBR stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Champions Oncology Business Description

Address One University Plaza, Suite 307, Hackensack, NJ, USA, 07601
Champions Oncology Inc is a USA based company which is engaged in the development and sale of state of the art technology solutions and products to personalize the development and use of oncology drugs. The company operates through one segment namely Personalized Oncology Solutions (POS) and Translational Oncology Solutions (TOS). Its POS business assists physicians in developing personalized treatment options for their cancer patients through tumor-specific data obtained from drug panels and related personalized oncology services. The TOS business assists pharmaceutical and biotechnology companies with their drug development process and offers studies or license tumors for use in studies. The company's revenue is majorly derived from research services.
61GF Score

Get the complete analysis for CSBR

Short Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$5.82
Price
$6.65
GF Value